QuickView for TTR;jsessionid=A8415CF42E5FDB6D3A1EFCBC186FCE7C;jsessionid=928A97796F822C54076E9F9D68461292;jsessionid=0997396F52B9FED44B483CB7627A0F22 (gene)

1. Therapeutic Strategies for Hereditary Transthyretin Amyloidosis].
2. Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even thou…
3. A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser.
4. Plasma transthyretin is a nutritional biomarker in human morbidities.
5. Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid.

There were no clinical trials for TTR;jsessionid=A8415CF42E5FDB6D3A1EFCBC186FCE7C;jsessionid=928A97796F822C54076E9F9D68461292;jsessionid=0997396F52B9FED44B483CB7627A0F22